TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9129960

Group type: EXPERIMENTAL
Intervention: 4‐3 and 4‐4 apoE phenotypes
Number of subjects: 1751

Group type: EXPERIMENTAL
Intervention: epsilon 4 allele
Number of subjects: 1751

Group type: COMPARATOR
Intervention: apoE phenotype
Number of subjects: 1751
Study: 7893582

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg daily for 2 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 0
Study: 2850682

Group type: EXPERIMENTAL
Intervention: Captopril (mean daily dose: 56 +/- 2 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Enalapril (mean daily dose: 9.6 +/- 0.9 mg)
Number of subjects: 24
Study: 29878501

Group type: EXPERIMENTAL
Intervention: 8-mg/day doxazosin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Doxazosin (4-mg/day and 8-mg/day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Doxazosin (8-mg/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 27167378

Group type: EXPERIMENTAL
Intervention: Psychological counseling and educational intervention
Number of subjects: 698

Group type: COMPARATOR
Intervention: Routine directly-observed anti-TB therapy
Number of subjects: 698
Study: 26189139

Group type: EXPERIMENTAL
Intervention: Secondary treatment with α1-blockers for 8 weeks
Number of subjects: 79
Study: 23784467

Group type: EXPERIMENTAL
Intervention: Dietary therapy of qi-yin-reinforcing porridge
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dextrin-prepared porridge (placebo control)
Number of subjects: 14
Study: 21155047

Group type: EXPERIMENTAL
Intervention: Single-injection femoral nerve block with 0.25% levobupivacaine (30 mL) combined with epidural analgesia
Number of subjects: 78

Group type: COMPARATOR
Intervention: Epidural analgesia alone (control group)
Number of subjects: 78
Study: 18196898

Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 17283003

Group type: EXPERIMENTAL
Intervention: Implantable defibrillator (ICD)
Number of subjects: 1866

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 1866
Study: 15646486

Group type: EXPERIMENTAL
Intervention: Nyolol Gel 0,1%
Number of subjects: 192

Group type: COMPARATOR
Intervention: Regular timolol treatment (Ofterisin 0,5%)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Timolol 0,1% gel formulation
Number of subjects: 192

Group type: COMPARATOR
Intervention: Timolol aqueous eye drops
Number of subjects: 192
Study: 11349617

Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg/day)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Nifedipine (40-80 mg/day)
Number of subjects: 244
Study: 9192486

Group type: EXPERIMENTAL
Intervention: Left ventricular assist devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dynamic cardiomyoplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partial left ventricular resection
Number of subjects: 0
Study: 8216503

Group type: EXPERIMENTAL
Intervention: Nicotinic acid (1 g t.d.s.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acipimox (placebo controlled)
Number of subjects: 0
Study: 3301913

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate mouthwash used 3 times daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate mouthwash
Number of subjects: 0
Study: 31874512

Group type: EXPERIMENTAL
Intervention: del Nido cardioplegia
Number of subjects: 84

Group type: COMPARATOR
Intervention: Thomas cardioplegia
Number of subjects: 84
Study: 28679349

Group type: EXPERIMENTAL
Intervention: CRT + HT
Number of subjects: 51

Group type: COMPARATOR
Intervention: CRT alone
Number of subjects: 51
Study: 27676398

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 335
Study: 24172721

Group type: EXPERIMENTAL
Intervention: Uphill interval treadmill training (GHill)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Level-grade interval treadmill training (GFlat)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (GCon)
Number of subjects: 32
Study: 22651572

Group type: EXPERIMENTAL
Intervention: Standard GH dose (43 μg/kg/day)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Individualized GH dose (17‐100 μg/kg/day)
Number of subjects: 127
Study: 19924675

Group type: EXPERIMENTAL
Intervention: Test dexchlorpheniramine 2.0 mg tablet (Eurofarma)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference dexchlorpheniramine 2.0 mg tablet (Celestamine, Schering‐Plough)
Number of subjects: 0
Study: 18577692

Group type: COMPARATOR
Intervention: Lower insulinemic-euglycemic clamp (100 pmol/l insulin, 5 mmol/l glucose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic-euglycemic clamp (400 pmol/l insulin, 5 mmol/l glucose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lower insulinemic-hyperglycemic clamp (100 pmol/l insulin, 12 mmol/l glucose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic-hyperglycemic clamp (400 pmol/l insulin, 12 mmol/l glucose)
Number of subjects: 6
Study: 15813287

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11889391

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (50 microg/100 mL, two puffs for each nostril once daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oxymetazoline (0.05%, one puff for each nostril three times daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3% Sodium chloride (NaCl, buffered to pH 6.5‐7, given three times daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.9% Sodium chloride (NaCl, 10-mL solutions for nasal irrigations three times daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No topical treatment (control group)
Number of subjects: 60
Study: 9698957

Group type: EXPERIMENTAL
Intervention: Continuous positive pressure ventilation (CPPV) plus surfactant (50 mg/kg body weight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CPPV only
Number of subjects: 20
Study: 7596744

Group type: EXPERIMENTAL
Intervention: Patterns presented at identical locations (ILs) on the skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patterns presented at varying distances between locations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patterns presented to corresponding points on separate fingerpads
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patterns presented to noncorresponding points on separate fingers
Number of subjects: 0
Study: 2141487

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 82

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 82
Study: 835326

Group type: EXPERIMENTAL
Intervention: Sympathectomy
Number of subjects: 183

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 183
Study: 30999596

Group type: EXPERIMENTAL
Intervention: Meal Replacement (MRP; 70% fat) consumed once daily for eight weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 42
Study: 26609965

Group type: EXPERIMENTAL
Intervention: High-impact aerobics (HIA)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-impact aerobics combined with strength training (LIAS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both groups (HIA and LIAS)
Number of subjects: 32
Study: 26560326

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 0
Study: 23912917

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (aspirin and clopidogrel)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Bare-metal stents
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Other medications
Number of subjects: 558
Study: 22121936

Group type: EXPERIMENTAL
Intervention: Enhanced multimedia version of CBT-I
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Book version of CBT-I
Number of subjects: 106

Group type: COMPARATOR
Intervention: Comparison group (no significant medical condition)
Number of subjects: 106
Study: 19230048

Group type: EXPERIMENTAL
Intervention: Group A: rabeprazole 10 mg + amoxicillin 1 g + furazolidone 100 mg + bismuth subcitrate 220 mg, twice daily for 1 week
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group B: same regimen as Group A but for 2 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group C: same regimen as Group B, but furazolidone was replaced by furazolidone 100 mg three times daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 17784949

Group type: EXPERIMENTAL
Intervention: 10 g lactulose daily for 4 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard medication alone
Number of subjects: 31
Study: 15491688

Group type: EXPERIMENTAL
Intervention: 7.5F ureteroscope
Number of subjects: 100

Group type: COMPARATOR
Intervention: 10F ureteroscope
Number of subjects: 100
Study: 11838823

Group type: EXPERIMENTAL
Intervention: Adjunctive haloperidol
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 5
Study: 9494310

Group type: EXPERIMENTAL
Intervention: Modified Infant Pain Scale (MIPS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 40
Study: 7768135

Group type: EXPERIMENTAL
Intervention: Baseline tilt table test (BTTT)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Multistage isoproterenol tilt table test (MITTT)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Single stage isoproterenol tilt table test (SITTT)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (normal controls)
Number of subjects: 144
Study: 3263812

Group type: EXPERIMENTAL
Intervention: Propofol (mean dosage 74 (SD 4) micrograms/kg/min for 0‐20 minutes and 51 (SD 7) micrograms/kg/min for 20‐40 minutes)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Midazolam (35 micrograms/kg + 2.54 (SD 0.2) micrograms/kg/min for 0‐20 minutes and 1.35 (SD 0.2) micrograms/kg/min for 20‐40 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline infusion (control group)
Number of subjects: 50
Study: 1233261

Group type: EXPERIMENTAL
Intervention: MK‐356 (525 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MK‐356 (2100 or 1050 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MK‐356 (400 mg probenecid coadministered with 700 mg pivampicillin)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Pivampicillin (350 mg)
Number of subjects: 32
Study: 30191365

Group type: EXPERIMENTAL
Intervention: Nivolumab + Ipilimumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 0
Study: 28728559

Group type: EXPERIMENTAL
Intervention: Dietary and therapeutic adjustments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current American Diabetes Association (ADA) usual recommendations for nutritional and pharmacological adjustments for exercise
Number of subjects: 0
Study: 26055239

Group type: EXPERIMENTAL
Intervention: 30-min daily exercise intervention (standing, upright exercise regimen)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 10
Study: 23417198

Group type: EXPERIMENTAL
Intervention: Gum chewing (two pieces of sugarless gum for 30 min in the morning, noon, evening, and bedtime until the first flatus, along with conventional postoperative feeding protocol)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Gum chewing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional feeding protocol without gum chewing
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Gum chewing and Conventional feeding protocol
Number of subjects: 50
Study: 21394549

Group type: EXPERIMENTAL
Intervention: 20-week progressive resistance training
Number of subjects: 74
Study: 18719924

Group type: EXPERIMENTAL
Intervention: Biofeedback therapy (BFB)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Botulinum neurotoxin A (BTX-A) injection
Number of subjects: 48

Group type: COMPARATOR
Intervention: Both BFB and BTX-A
Number of subjects: 48
Study: 17938015

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 0
Study: 15061154

Group type: EXPERIMENTAL
Intervention: Citalopram (level 1)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Sertraline, Bupropion, Venlafaxine, Cognitive Therapy (level 2 switch options)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (level 2 augment option)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Mirtazapine, Nortriptyline (level 3 switch options)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Lithium, Thyroid Hormone (level 3 augment options)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Tranylcypromine, Combination of Mirtazapine and Venlafaxine (level 4 switch options)
Number of subjects: 4000
Study: 11565941

Group type: EXPERIMENTAL
Intervention: Physical Practice
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined Mental and Physical Practice
Number of subjects: 60

Group type: COMPARATOR
Intervention: No Practice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mental Practice
Number of subjects: 60
Study: 9354195

Group type: EXPERIMENTAL
Intervention: Ranitidine 75 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8249560

Group type: EXPERIMENTAL
Intervention: N2O group (isoflurane in nitrous oxide and 30% oxygen)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Air group (isoflurane in air and 30% oxygen)
Number of subjects: 36
Study: 3307670

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study: 29582084

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 1089
Study: 26621110

Group type: EXPERIMENTAL
Intervention: Formalin (24 h further fixation)
Number of subjects: 200

Group type: COMPARATOR
Intervention: GEWF immersion
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 200
Study: 23657087

Group type: EXPERIMENTAL
Intervention: Recovery of colonic transit (geometric center of radioactivity ≥2 on day 3)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combined outcome measure of tolerance of solid food and having had defecation (SF + D)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: SF + D
Number of subjects: 84

Group type: COMPARATOR
Intervention: Time to first flatus
Number of subjects: 84
Study: 23780807

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medications (including statins)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medications (after 2002)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medications (trend after 2002)
Number of subjects: 0
Study: 20519680

Group type: EXPERIMENTAL
Intervention: Pallidal stimulation
Number of subjects: 299

Group type: COMPARATOR
Intervention: Subthalamic stimulation
Number of subjects: 299
Study: 20467622

Group type: EXPERIMENTAL
Intervention: 0.8% hyaluronic acid
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (carrier)
Number of subjects: 72
Study: 16007328

Group type: EXPERIMENTAL
Intervention: Neridronate therapy with calcium + vitamin D
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium + vitamin D alone (control group)
Number of subjects: 0
Study: 12824258

Group type: EXPERIMENTAL
Intervention: Adenosine (40 microg/kg per minute, 30 minutes per infusion step)
Number of subjects: 12
Study: 12861835

Group type: COMPARATOR
Intervention: Phentolamine and papaverine (Group 1)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Phentolamine, papaverine, and ligustrazin hydrochloride (Group 2)
Number of subjects: 56
Study: 10468312

Group type: EXPERIMENTAL
Intervention: Tiapride 100 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lorazepam 1 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8647479

Group type: EXPERIMENTAL
Intervention: Pregnancy-induced hypertension (PIH)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal pregnancy (Control)
Number of subjects: 32
Study: 1369845

Group type: EXPERIMENTAL
Intervention: Fixation with K-wires of the opposite hip as prophylaxis against slipping
Number of subjects: 47
Study: 324417

Group type: EXPERIMENTAL
Intervention: Intraoperative antibiotic wound lavage
Number of subjects: 434

Group type: COMPARATOR
Intervention: Normal saline irrigation
Number of subjects: 434

Group type: COMPARATOR
Intervention: Antibiotic solution irrigation
Number of subjects: 434

Group type: COMPARATOR
Intervention: No antibiotic wound lavage
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Intraoperative wound lavage
Number of subjects: 434
Study: 31773882

Group type: EXPERIMENTAL
Intervention: PVP-I foam dressing
Number of subjects: 71

Group type: COMPARATOR
Intervention: Foam dressing (Medifoam)
Number of subjects: 71
Study: 28249808

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (suture only)
Number of subjects: 30
Study: 25482832

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg orally daily for 24 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Histologic responders
Number of subjects: 50
Study: 23332288

Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m2) plus cisplatin (75 mg/m2)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Pemetrexed (500 mg/m2) plus carboplatin (AUC 6)
Number of subjects: 130
Study: 20154505

Group type: EXPERIMENTAL
Intervention: Increased knee extension strength
Number of subjects: 417
Study: 17888680

Group type: EXPERIMENTAL
Intervention: Central posteroanterior (PA) mobilisation to L3 for 2 minutes
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (no active intervention)
Number of subjects: 36
Study: 16776916

Group type: EXPERIMENTAL
Intervention: Amiodarone alone
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Amiodarone plus losartan
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Amiodarone plus perindopril
Number of subjects: 181
Study: 15600384

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 317

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 317
Study: 11775652

Group type: EXPERIMENTAL
Intervention: Essaven gel (EG)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 9709270

Group type: EXPERIMENTAL
Intervention: Intervention group invited to screening
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group not invited to screening
Number of subjects: 7
Study: 8020529

Group type: EXPERIMENTAL
Intervention: Asiatic acid (12 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Asiaticoside (24 mg)
Number of subjects: 12
Study: 29271805

Group type: EXPERIMENTAL
Intervention: Primary Eye Care (PEC)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Tertiary Specialist Outpatient Clinic (SOC)
Number of subjects: 233
Study: 27580837

Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 344

Group type: COMPARATOR
Intervention: Physiotherapy-led best conservative care
Number of subjects: 344
Study: 23300047

Group type: EXPERIMENTAL
Intervention: Health advertisements
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Advertisements attributed to a nonprofit source
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Commercial advertisements rated as credible
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Appearance condition advertisements attributed to a nonprofit source
Number of subjects: 227
Study: 22182435

Group type: EXPERIMENTAL
Intervention: Fat grafts mixed with PRP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonablative laser
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fat grafts mixed with PRP plus nonablative laser resurfacing
Number of subjects: 60
Study: 20225911

Group type: EXPERIMENTAL
Intervention: Telephone intervention to improve quality of life among patients with CHF
Number of subjects: 458

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 458
Study: 18279476

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 22 mg 0.8 ml(‐1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 22
Study: 16006455

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy first (DLSF) group
Number of subjects: 154

Group type: COMPARATOR
Intervention: IUI first (IUIF) group
Number of subjects: 154
Study: 12469157

Group type: EXPERIMENTAL
Intervention: 10(6) units of macrophage colony-stimulating factor (low dose group)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: 8x10(6) units of macrophage colony-stimulating factor (high dose group)
Number of subjects: 214
Study: 10673196

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg combined with fluticasone propionate (FP) 250 microg
Number of subjects: 349

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349

Group type: COMPARATOR
Intervention: Salmeterol 50 microg
Number of subjects: 349

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 250 microg
Number of subjects: 349
Study: 8897961

Group type: EXPERIMENTAL
Intervention: dobutamine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: dopamine
Number of subjects: 15
Study: 1815717

Group type: EXPERIMENTAL
Intervention: Prema Compound
Number of subjects: 21

Group type: COMPARATOR
Intervention: 12-fluted bur
Number of subjects: 21
Study: 6511154

Group type: EXPERIMENTAL
Intervention: Androgenic steroids (average 45 mg/day) during an 8-week strength training period
Number of subjects: 7